Assignee
CUREVAC AG
DE83 patents
Top patents by PatentIndex Score
US11078247B2Aug 3, 2021
RNA encoding a therapeutic protein
CUREVAC AG57 citations98
US10912826B2Feb 9, 2021
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC AG45 citations98
US10799577B2Oct 13, 2020
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC AG28 citations98
US10738306B2Aug 11, 2020
Artificial nucleic acid molecules for improved protein or peptide expression
CUREVAC AG36 citations98
US10682406B2Jun 16, 2020
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC AG29 citations98
US10434158B2Oct 8, 2019
Combination of vaccination and inhibition of the PD-1 pathway
CUREVAC AG31 citations98
US10166283B2Jan 1, 2019
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC AG37 citations98
US10117920B2Nov 6, 2018
Combination of vaccination and inhibition of the PD-1 pathway
CUREVAC AG32 citations98
US10111968B2Oct 30, 2018
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
CUREVAC AG39 citations98
US9974845B2May 22, 2018
Combination of vaccination and inhibition of the PD-1 pathway
CUREVAC AG32 citations98
US9907862B2Mar 6, 2018
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
CUREVAC AG35 citations98
US9839697B2Dec 12, 2017
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
CUREVAC AG39 citations98
US11266735B2Mar 8, 2022
Combination vaccine
CUREVAC AG40 citations97
US11179337B2Nov 23, 2021
Dry powder composition comprising long-chain RNA
CUREVAC AG35 citations97
US11149278B2Oct 19, 2021
Artificial nucleic acid molecules for improved protein expression
CUREVAC AG31 citations97
US11135312B2Oct 5, 2021
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
CUREVAC AG35 citations97
US11034729B2Jun 15, 2021
Respiratory syncytial virus (RSV) vaccine
CUREVAC AG35 citations97
US10918740B2Feb 16, 2021
RNA containing composition for treatment of tumor diseases
CUREVAC AG38 citations97
US10729761B2Aug 4, 2020
Vaccination in newborns and infants
CUREVAC AG30 citations97
US10596252B2Mar 24, 2020
Vaccination in newborns and infants
CUREVAC AG30 citations97
US10568972B2Feb 25, 2020
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
CUREVAC AG35 citations97
US10293058B2May 21, 2019
RNA containing composition for treatment of tumor diseases
CUREVAC AG50 citations97
US10172935B2Jan 8, 2019
Vaccination in newborns and infants
CUREVAC AG33 citations97
US10150797B2Dec 11, 2018
Respiratory syncytial virus (RSV) vaccine
CUREVAC AG39 citations97
US9688729B2Jun 27, 2017
Respiratory syncytial virus (RSV) vaccine
CUREVAC AG66 citations97
US9655955B2May 23, 2017
Application of mRNA for use as a therapeutic against tumour diseases
CUREVAC AG42 citations97
US9463228B2Oct 11, 2016
Application of mRNA for use as a therapeutic against tumour diseases
CUREVAC AG28 citations97
US9439956B2Sep 13, 2016
Application of mRNA for use as a therapeutic against tumour diseases
CUREVAC AG29 citations97
US9433670B2Sep 6, 2016
Application of mRNA for use as a therapeutic against tumour diseases
CUREVAC AG29 citations97
US9433669B2Sep 6, 2016
Application of mRNA for use as a therapeutic against tumor diseases
CUREVAC AG29 citations97
US10517827B2Dec 31, 2019
Dry powder composition comprising long-chain RNA
CUREVAC AG35 citations96
US11254951B2Feb 22, 2022
Artificial nucleic acid molecules
CUREVAC AG28 citations95
US11458195B2Oct 4, 2022
Combination of vaccination and inhibition of the PD-1 pathway
CUREVAC AG12 citations94
US11241493B2Feb 8, 2022
Coronavirus vaccine
CUREVAC AG54 citations94
US11141476B2Oct 12, 2021
MERS coronavirus vaccine
CUREVAC AG29 citations94
US11110166B2Sep 7, 2021
Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
CUREVAC AG32 citations94
US11110156B2Sep 7, 2021
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
CUREVAC AG28 citations94
US10898589B2Jan 26, 2021
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
CUREVAC AG28 citations94
US10898584B2Jan 26, 2021
Modified RNA with decreased immunostimulatory properties
CUREVAC AG30 citations94
US10799602B2Oct 13, 2020
Method for increasing expression of RNA-encoded proteins
CUREVAC AG36 citations94
US10751424B2Aug 25, 2020
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
CUREVAC AG29 citations94
US10682426B2Jun 16, 2020
Rabies vaccine
CUREVAC AG30 citations94
US10653799B2May 19, 2020
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein
CUREVAC AG28 citations94
US10610605B2Apr 7, 2020
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
CUREVAC AG28 citations94
US10588959B2Mar 17, 2020
Combination vaccine
CUREVAC AG30 citations94
US10568958B2Feb 25, 2020
Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates
CUREVAC AG30 citations94
US10293060B2May 21, 2019
Method for increasing expression of RNA-encoded proteins
CUREVAC AG30 citations94
US10232024B2Mar 19, 2019
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded allergenic antigen or an autoimmune self-antigen
CUREVAC AG32 citations94
US10111967B2Oct 30, 2018
Complexes of RNA and cationic peptides for transfection and for immunostimulation
CUREVAC AG30 citations94
US10080809B2Sep 25, 2018
Artificial nucleic acid molecules comprising a 5′TOP UTR
CUREVAC AG34 citations94
Showing the top 50 of 83 patents by PatentIndex Score.